KONINKLIJKE PHILIPS NV (PHIA.AS) Stock Fundamental Analysis
AMS:PHIA - Euronext Amsterdam - NL0000009538 - Common Stock - Currency: EUR
Taking everything into account, PHIA scores 3 out of 10 in our fundamental rating. PHIA was compared to 53 industry peers in the Health Care Equipment & Supplies industry. PHIA has a bad profitability rating. Also its financial health evaluation is rather negative. PHIA is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
PHIA had positive earnings in the past year.
In the past year PHIA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: PHIA reported negative net income in multiple years.
Of the past 5 years PHIA 4 years had a positive operating cash flow.
1.2 Ratios
PHIA's Return On Assets of -2.42% is in line compared to the rest of the industry. PHIA outperforms 43.40% of its industry peers.
The Return On Equity of PHIA (-5.85%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.42% | ||
| ROE | -5.85% | ||
| ROIC | N/A |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHIA's Operating Margin has declined in the last couple of years.
PHIA's Gross Margin of 43.13% is on the low side compared to the rest of the industry. PHIA is outperformed by 69.81% of its industry peers.
In the last couple of years the Gross Margin of PHIA has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for PHIA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.13% |
OM growth 3Y-2.25%
OM growth 5Y-8.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
PHIA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PHIA has been reduced compared to 1 year ago.
The number of shares outstanding for PHIA has been increased compared to 5 years ago.
The debt/assets ratio for PHIA is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.59, we must say that PHIA is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.59, PHIA is in line with its industry, outperforming 50.94% of the companies in the same industry.
PHIA has a debt to FCF ratio of 8.68. This is a slightly negative value and a sign of low solvency as PHIA would need 8.68 years to pay back of all of its debts.
PHIA has a Debt to FCF ratio (8.68) which is comparable to the rest of the industry.
PHIA has a Debt/Equity ratio of 0.59. This is a neutral value indicating PHIA is somewhat dependend on debt financing.
PHIA's Debt to Equity ratio of 0.59 is on the low side compared to the rest of the industry. PHIA is outperformed by 62.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 8.68 | ||
| Altman-Z | 1.59 |
ROIC/WACCN/A
WACC6.28%
2.3 Liquidity
A Current Ratio of 1.23 indicates that PHIA should not have too much problems paying its short term obligations.
With a Current ratio value of 1.23, PHIA is not doing good in the industry: 62.26% of the companies in the same industry are doing better.
A Quick Ratio of 0.84 indicates that PHIA may have some problems paying its short term obligations.
PHIA has a Quick ratio of 0.84. This is in the lower half of the industry: PHIA underperforms 60.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.23 | ||
| Quick Ratio | 0.84 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 11.72% over the past year.
Measured over the past years, PHIA shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.17% on average per year.
Looking at the last year, PHIA shows a decrease in Revenue. The Revenue has decreased by -0.82% in the last year.
The Revenue has been growing slightly by 1.00% on average over the past years.
EPS 1Y (TTM)11.72%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%24.39%
Revenue 1Y (TTM)-0.82%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.36%
3.2 Future
PHIA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.99% yearly.
The Revenue is expected to grow by 3.55% on average over the next years.
EPS Next Y9.94%
EPS Next 2Y11.54%
EPS Next 3Y12.13%
EPS Next 5Y12.99%
Revenue Next Year3.9%
Revenue Next 2Y4.18%
Revenue Next 3Y4.38%
Revenue Next 5Y3.55%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 15.87, the valuation of PHIA can be described as correct.
Based on the Price/Earnings ratio, PHIA is valued cheaper than 84.91% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.79. PHIA is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 14.48, the valuation of PHIA can be described as correct.
PHIA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PHIA is cheaper than 73.58% of the companies in the same industry.
PHIA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.87 | ||
| Fwd PE | 14.48 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PHIA is valued a bit cheaper than the industry average as 66.04% of the companies are valued more expensively.
79.25% of the companies in the same industry are more expensive than PHIA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.56 | ||
| EV/EBITDA | 18.53 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as PHIA's earnings are expected to grow with 12.13% in the coming years.
PEG (NY)1.6
PEG (5Y)N/A
EPS Next 2Y11.54%
EPS Next 3Y12.13%
5. Dividend
5.1 Amount
PHIA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMS:PHIA (4/25/2025, 7:00:00 PM)
22.06
+0.4 (+1.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners48.26%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap20.74B
Analysts73.08
Price Target29.01 (31.5%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP-0.14%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-14.27%
Min EPS beat(2)-16.56%
Max EPS beat(2)-11.97%
EPS beat(4)0
Avg EPS beat(4)-12.16%
Min EPS beat(4)-16.56%
Max EPS beat(4)-6.96%
EPS beat(8)2
Avg EPS beat(8)0.79%
EPS beat(12)3
Avg EPS beat(12)3.3%
EPS beat(16)5
Avg EPS beat(16)1.18%
Revenue beat(2)0
Avg Revenue beat(2)-4.13%
Min Revenue beat(2)-5.22%
Max Revenue beat(2)-3.04%
Revenue beat(4)0
Avg Revenue beat(4)-3.42%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-2.46%
Revenue beat(8)1
Avg Revenue beat(8)-2.64%
Revenue beat(12)2
Avg Revenue beat(12)-1.69%
Revenue beat(16)2
Avg Revenue beat(16)-2.44%
PT rev (1m)0%
PT rev (3m)0.2%
EPS NQ rev (1m)-12.16%
EPS NQ rev (3m)-2.2%
EPS NY rev (1m)-2.3%
EPS NY rev (3m)-8.98%
Revenue NQ rev (1m)-2.06%
Revenue NQ rev (3m)-3.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.44%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.87 | ||
| Fwd PE | 14.48 | ||
| P/S | 1.15 | ||
| P/FCF | 23.56 | ||
| P/OCF | 13.33 | ||
| P/B | 1.73 | ||
| P/tB | N/A | ||
| EV/EBITDA | 18.53 |
EPS(TTM)1.39
EY6.3%
EPS(NY)1.52
Fwd EY6.9%
FCF(TTM)0.94
FCFY4.24%
OCF(TTM)1.66
OCFY7.5%
SpS19.17
BVpS12.77
TBVpS-1.45
PEG (NY)1.6
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.42% | ||
| ROE | -5.85% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.13% | ||
| FCFM | 4.88% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.25%
OM growth 5Y-8.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score6
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 8.68 | ||
| Debt/EBITDA | 5.15 | ||
| Cap/Depr | 48.63% | ||
| Cap/Sales | 3.75% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 112.67% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.23 | ||
| Quick Ratio | 0.84 | ||
| Altman-Z | 1.59 |
F-Score6
WACC6.28%
ROIC/WACCN/A
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.72%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%24.39%
EPS Next Y9.94%
EPS Next 2Y11.54%
EPS Next 3Y12.13%
EPS Next 5Y12.99%
Revenue 1Y (TTM)-0.82%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.36%
Revenue Next Year3.9%
Revenue Next 2Y4.18%
Revenue Next 3Y4.38%
Revenue Next 5Y3.55%
EBIT growth 1Y91.51%
EBIT growth 3Y-0.63%
EBIT growth 5Y-7.54%
EBIT Next Year57.53%
EBIT Next 3Y22.84%
EBIT Next 5YN/A
FCF growth 1Y-45.51%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y-31.12%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%